KATE OKOROAFO: Open Payments
NPI 1700433760 · HOBBS, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $185 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $244 |
| Neurocrine BioSciences, Inc. | 2 | $155 |
| Axsome Therapeutics, Inc. | 2 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
Products named: UZEDY, INGREZZA, Auvelity, CAPLYTA.
Industry payments across NM — which companies pay providers there.
